Further, in a subgroup analysis of FREEDOM trial, type 2 diabetes mellitus with multi vessel CAD, the rate of MACE was higher in insulin provisioning treatment group than in those who were restricted for insulin treatment, even after adjusting for clinical demographics, severity of the disease and revascularization treatment [26]. Here, INS is linked to type 2 diabetes mellitus.